Immune-Onc Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Immune-Onc Therapeutics

Access the complete profile.

Immune-Onc Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	339112 Surgical & Medical Instrument Manufacturing
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	795 San Antonio Road Palo Alto, CA 94303

Note: Revenues for privately held companies are statistical evaluations.


Immune-Onc Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Immune-Onc Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Immune-Onc Therapeutics is classified as operating in the Surgical & Medical Instrument Manufacturing industry, NAICS Code 339112.

Immune-Onc Therapeutics Annual Revenue and Growth Rate

Immune-Onc Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Immune-Onc Therapeutics's revenues are gauged from an analysis of company filings.

Immune-Onc Therapeutics's Income Statement (based on Industry Averages)

Immune-Onc Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Immune-Onc Therapeutics is developing and marketing. Immune-Onc Therapeutics doesn't have any recent trademark applications, indicating Immune-Onc Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
IMMUNE-ONC THERAPEUTICS Development of pharmaceutical preparations and medicines; Research and development of vaccines and medicines; Basic and clinical research in the field of respiratory science and medicine; Scientific study and research in the field of medicine; Scientific study and research in the field of healthcare products	09/06/2016
IMMUNE-ONC Development of pharmaceutical preparations and medicines; Research and development of vaccines and medicines; Basic and clinical research in the field of respiratory science and medicine; Scientific study and research in the field of medicine; Scientific study and research in the field of healthcare products	09/06/2016

See all trademarks and details in the Full Report.

Market Share of Immune-Onc Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Immune-Onc Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
EMBECTA	Parsippany, NJ	100
STRUCTURE MEDICAL	Mooresville, NC	34
AUTOCAM MEDICAL DEVICES	Kentwood, MI	30
SCHARNBERG HOLDING	Des Moines, IA	26
SPECIALTY SURGICAL INSTRUMENTATION	Antioch, TN	24
MIDWEST INTERVENTIONAL SYSTEMS	Maple Grove, MN	19
VITA NEEDLE	Needham, MA	17
PYLANT MEDICAL	Grapevine, TX	17
MEDTEC	Orange City, IA	16

Nearby Competitors

These companies are similar in business line and location to Immune-Onc Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SCITON	Palo Alto, CA	100
RECOR MEDICAL	Palo Alto, CA	21
IMMUNE-ONC THERAPEUTICS	Palo Alto, CA	8
BIOINSPIRE TECHNOLOGIES	Palo Alto, CA	1

Future Competition: Immune-Onc Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Immune-Onc Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)